Tocilizumab

Print
Date: May 2025, Version 2.0

Quick take

Tocilizumab can be used in pregnancy if advised by a specialist. Babies exposed in the womb after the first trimester might be offered some of their vaccinations later than usual.

What is it?

Tocilizumab (RoActemra®, Tyenne®) is an antibody therapy used to treat rheumatoid arthritis and severe COVID-19. Tocilizumab is also used to treat giant cell arteritis, but this tends to affect people over 50 years old and so is very rare in pregnancy.

Benefits

What are the benefits of using tocilizumab in pregnancy?

Tocilizumab reduces inflammation in rheumatoid arthritis by stopping your immune system from attacking your body’s tissues. This is important to reduce unpleasant symptoms and prevent long-term joint damage. Tocilizumab may also lower the chance of some pregnancy problems linked to uncontrolled inflammation, including miscarriage and lower infant birth weight. 

Tocilizumab can help people who are in hospital with severe COVID-19 to recover more quickly.

Risks

What are the risks of using tocilizumab in pregnancy?

Tocilizumab does not cross the placenta in the first trimester so will not directly affect your baby’s development. Only around 50 women using tocilizumab in later pregnancy have been studied. No problems were identified but further research is ideally required.

Tocilizumab used in later pregnancy can affect the baby’s immune system for several months after birth. Live vaccines should be avoided during this time. This means that the baby will not be offered vaccination against rotavirus (as this needs to be completed by four months of age) and is unlikely to be offered the BCG vaccine (if required) until they are at least six months old. A doctor will be able to advise about the best time for your baby to be given any live vaccinations.

Alternatives

Are there any alternatives to using tocilizumab in pregnancy?

Possibly. Other medicines can be used to treat rheumatoid arthritis during pregnancy, although these may not work as well as tocilizumab. If tocilizumab is working for you, staying on it during pregnancy may be your best option.

Tocilizumab is only used to treat severe COVID-19 in pregnancy when your doctor thinks it is the best option to help you recover and to prevent pregnancy complications.
  
If you are planning a pregnancy or have an unplanned pregnancy while being treated for rheumatoid arthritis, speak to your specialist about which medicine is best.

No treatment

What if I prefer not to take tocilizumab during pregnancy?

It is important that rheumatoid arthritis is well-treated during pregnancy to avoid a flare-up of your symptoms and reduce the chance of certain pregnancy complications. It is also important that severe COVID-19 is treated correctly as this can be very serious during pregnancy. Your doctor will be happy to discuss any concerns.

Will I or my baby need extra monitoring?

As part of routine antenatal care in the UK, women are invited for a very detailed scan at around 20 weeks of pregnancy to check the baby’s development. No further scans to check for birth defects will be required, although extra growth scans may be offered to women with rheumatoid arthritis or who have had severe COVID-19.

Are there any risks to my baby if the father has used tocilizumab?

There is currently no evidence that tocilizumab used by the father can harm your baby through effects on the sperm.

Who can I talk to if I have questions?

If you have any questions regarding the information in this leaflet, please discuss them with your health care provider. They can access more detailed medical and scientific information from www.uktis.org.

How can I help to improve drug safety information for pregnant women in the future?

Our online reporting system (MyBump Portal) allows women who are currently pregnant to create a secure record of their pregnancy, collected through a series of questionnaires. You will be asked to enter information about your health, whether or not you take any medicines, your pregnancy outcome and your child's development. You can update your details at any time during pregnancy or afterwards. This information will help us better understand how medicines affect the health of pregnant women and their babies. Please visit the MyBump Portal to register.

General information
Sadly, miscarriage and birth defects can occur in any pregnancy.

Miscarriage occurs in about 1 in every 5 pregnancies, and 1 in every 40 babies are born with a birth defect. This is called the ‘background risk’ and happens whether medication is taken or not.

Most medicines cross the placenta and reach the baby. For many medications this is not a problem. However, some medicines can affect a baby’s growth and development.

If you take regular medication and are planning to conceive, you should discuss whether your medicine is safe to continue with your doctor/health care team before becoming pregnant. If you have an unplanned pregnancy while taking a medicine, you should tell your doctor as soon as possible.

If a new medicine is suggested for you during pregnancy, please make sure that the person prescribing it knows that you are pregnant. If you have any concerns about a medicine, you can check with your doctor, midwife or pharmacist.

Our Bumps information leaflets provide information about the effects of medicines in pregnancy so that you can decide, together with your healthcare provider, what is best for you and your baby.